Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Friday, April 19, 2024 | Back issues
Courthouse News Service Courthouse News Service

Drug Antitrust

MANHATTAN - Actavis and Forest Laboratories are interfering with production of a generic form of a blockbuster Alzheimer's drug, Namenda, the New York attorney general claims in a federal antitrust complaint.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...